Literature DB >> 30997984

pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells.

Yan Gao, Li Jia1, Qi Wang, Haiyang Hu, Xiuli Zhao, Dawei Chen, Mingxi Qiao.   

Abstract

The enhanced endo-lysosomal sequestration still remains a big challenge in overcoming multidrug resistance (MDR). Herein, a dual-responsive polyplex with effective endo-lysosomal escape based on methoxypoly(ethylene glycol)-polylactide-polyhistidine-ss-oligoethylenimine (mPEG- b-PLA-PHis-ssOEI) was developed for codelivering MDR1 siRNA and doxorubicin (DOX). The polyplex showed good encapsulation of DOX and siRNA as well as triggered payload release in response to pH/redox stimuli because of the PHis protonation and the disulfide bond cleavage. The polyplex at an N/P ratio of 7 demonstrated a much higher payload delivery efficiency, MDR1 gene silence efficiency, cytotoxicity against MCF-7/ADR cell, and stronger MCF-7/ADR tumor growth inhibition than the polyplexes at higher N/P ratios. This was attributed to the stronger electrostatic attraction between siRNA and OEIs at higher N/P ratios that suppressed the release of MDR1 siRNA and OEIs, which played a dominant role in overcoming payload endo-lysosomal sequestration by the OEI-induced membrane permeabilization effect. Consequently, the polyplex with effective endo-lysosomal escape provides a rational approach for codelivery of siRNAs and chemotherapy agents for MDR reversal.

Entities:  

Keywords:  MDR; codelivery; endosomal escape; pH sensitive; redox sensitive; siRNA delivery

Mesh:

Substances:

Year:  2019        PMID: 30997984     DOI: 10.1021/acsami.9b02016

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  17 in total

Review 1.  Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.

Authors:  Xianglei Fu; Yanbin Shi; Tongtong Qi; Shengnan Qiu; Yi Huang; Xiaogang Zhao; Qifeng Sun; Guimei Lin
Journal:  Signal Transduct Target Ther       Date:  2020-11-06

2.  Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.

Authors:  Jialang Zhuang; Siqi Chen; Ye Hu; Fan Yang; Qin Huo; Ni Xie
Journal:  Int J Nanomedicine       Date:  2021-03-08

Review 3.  pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications.

Authors:  Rimesh Augustine; Nagendra Kalva; Ho An Kim; Yu Zhang; Il Kim
Journal:  Molecules       Date:  2019-08-15       Impact factor: 4.411

4.  A Valid Bisphosphonate Modified Calcium Phosphate-Based Gene Delivery System: Increased Stability and Enhanced Transfection Efficiency In Vitro and In Vivo.

Authors:  Ming Zhao; Ji Li; Dawei Chen; Haiyang Hu
Journal:  Pharmaceutics       Date:  2019-09-11       Impact factor: 6.321

Review 5.  Recent Advances in Stimulus-Responsive Nanocarriers for Gene Therapy.

Authors:  Cheng Yu; Long Li; Pei Hu; Yan Yang; Wei Wei; Xin Deng; Lu Wang; Franklin R Tay; Jingzhi Ma
Journal:  Adv Sci (Weinh)       Date:  2021-05-16       Impact factor: 16.806

6.  Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy.

Authors:  Chunai Gong; Xiaoyan Yu; Benming You; Yan Wu; Rong Wang; Lu Han; Yujie Wang; Shen Gao; Yongfang Yuan
Journal:  J Nanobiotechnology       Date:  2020-06-16       Impact factor: 10.435

7.  Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance.

Authors:  Yinghuan Li; Xi Tan; Xuhan Liu; Lingyan Liu; Yan Fang; Rong Rao; Yuanyuan Ren; Xiangliang Yang; Wei Liu
Journal:  Asian J Pharm Sci       Date:  2019-11-12       Impact factor: 6.598

8.  A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.

Authors:  Na Chang; Yufei Zhao; Ning Ge; Liting Qian
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.819

9.  Transport Oligonucleotides-A Novel System for Intracellular Delivery of Antisense Therapeutics.

Authors:  Oleg V Markov; Anton V Filatov; Maxim S Kupryushkin; Ivan V Chernikov; Olga A Patutina; Anton A Strunov; Elena L Chernolovskaya; Valentin V Vlassov; Dmitrii V Pyshnyi; Marina A Zenkova
Journal:  Molecules       Date:  2020-08-11       Impact factor: 4.411

Review 10.  Designing Nanoparticle-based Drug Delivery Systems for Precision Medicine.

Authors:  Jianhua Yang; Chengyou Jia; Jianshe Yang
Journal:  Int J Med Sci       Date:  2021-06-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.